JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 11 1808-1812
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinmann, P.
Right arrow Articles by Lebtahi, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Weinmann, P.
Right arrow Articles by Lebtahi, R.

111In-Pentetreotide Scintigraphy in Patients with Langerhans' Cell Histiocytosis

Pierre Weinmann, Bruno Crestani, Abdelatif Tazi, Thierry Genereau, Hervé Mal, Michel Aubier, Dominique Valeyre, Jean-Luc Moretti, Dominique Le Guludec and Rachida Lebtahi

Nuclear Medicine and Pneumology Departments, Avicenne Hospital, Paris; Nuclear Medicine and Pneumology Departments, Bichat Hospital, Paris; Internal Medicine Department, Pitié Hospital, Paris; and Pneumology Department, Beaujon Hospital, Paris, France


Figure 1
View larger version (66K):
[in this window]
[in a new window]

 
FIGURE 1. 111In-pentetreotide scintigraphy of patient 2. Planar anterior (A) and posterior (B) views of chest reveal bilateral increased lung uptake (lung-to-shoulder ratio, 2.90). (C) Transverse tomographic images reveal diffuse increased uptake.

 

Figure 2
View larger version (126K):
[in this window]
[in a new window]

 
FIGURE 2. 111In-pentetreotide scintigraphy of patient 1. Planar anterior views of left (A) and right (B) upper limbs, pelvis (C), and inferior limbs (D). Note increased uptake of 111In-pentetreotide in soft tissues around shoulders, hips, and knees.

 

Figure 3
View larger version (95K):
[in this window]
[in a new window]

 
FIGURE 3. 111In-pentetreotide scintigraphy of patient 13. Planar anterior (A) and posterior (B) views of inferior limbs. Note increased uptake of 111In-pentetreotide in right distal femur and knee and in left knee.

 

Figure 4
View larger version (122K):
[in this window]
[in a new window]

 
FIGURE 4. 111In-pentetreotide scintigraphy of patient 3. Planar anterior (A) and posterior (B) views of chest reveal bilateral increased lung uptake (lung-to-shoulder ratio, 2.59) and abnormal accumulation on salivary glands (A, arrows) and in axillary region (A, arrowheads). On posterior view of head (D), note increased uptake of 111In-pentetreotide of left ear region (arrow), which is faintly visible on anterior view (C).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.